Perioperative Low-dose Dexmedetomidine Decreases Incidence of Delirium in Liver Transplant Patients
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium; Sedation
- Focus Therapeutic Use
- 26 Nov 2017 Planned End Date changed from 1 Jul 2017 to 1 Feb 2018.
- 26 Nov 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 03 Nov 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Nov 2015)